WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
WAVE 生命科學股票：深入了解分析師觀點（5 個評級）
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on WAVE Life Sciences (NASDAQ:WVE) in the last three months.
在過去三個月中，有5位分析師公佈了對WAVE Life Sciences（納斯達克股票代碼：WVE）的評級，提供了從看漲到看跌的不同視角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $13.4, along with a high estimate of $19.00 and a low estimate of $5.00. This current average reflects an increase of 14.82% from the previous average price target of $11.67.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲13.4美元，最高估計爲19.00美元，低估值爲5.00美元。目前的平均價格比之前的平均目標價11.67美元增長了14.82％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
A comprehensive examination of how financial experts...
對金融專家如何...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。